Literature DB >> 16400613

A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.

Catarina Quinzii1, Ali Naini, Leonardo Salviati, Eva Trevisson, Placido Navas, Salvatore Dimauro, Michio Hirano.   

Abstract

Ubiquinone (coenzyme Q(10) or CoQ(10)) is a lipid-soluble component of virtually all cell membranes, where it functions as a mobile electron and proton carrier. CoQ(10) deficiency is inherited as an autosomal recessive trait and has been associated with three main clinical phenotypes: a predominantly myopathic form with central nervous system involvement, an infantile encephalomyopathy with renal dysfunction, and an ataxic form with cerebellar atrophy. In two siblings of consanguineous parents with the infantile form of CoQ(10) deficiency, we identified a homozygous missense mutation in the COQ2 gene, which encodes para-hydroxybenzoate-polyprenyl transferase. The A-->G transition at nucleotide 890 changes a highly conserved tyrosine to cysteine at amino acid 297 within a predicted transmembrane domain. Radioisotope assays confirmed a severe defect of CoQ(10) biosynthesis in the fibroblasts of one patient. This mutation in COQ2 is the first molecular cause of primary CoQ(10) deficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16400613      PMCID: PMC1380241          DOI: 10.1086/500092

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines.

Authors:  Gloria Brea-Calvo; Angeles Rodríguez-Hernández; Daniel J M Fernández-Ayala; Plácido Navas; José A Sánchez-Alcázar
Journal:  Free Radic Biol Med       Date:  2005-12-13       Impact factor: 7.376

2.  Delayed-onset ataxia in mice lacking alpha -tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress.

Authors:  T Yokota; K Igarashi; T Uchihara; K Jishage; H Tomita; A Inaba; Y Li; M Arita; H Suzuki; H Mizusawa; H Arai
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

3.  Familial cerebellar ataxia with muscle coenzyme Q10 deficiency.

Authors:  O Musumeci; A Naini; A E Slonim; N Skavin; G L Hadjigeorgiou; N Krawiecki; B M Weissman; C Y Tsao; J R Mendell; S Shanske; D C De Vivo; M Hirano; S DiMauro
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

4.  Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency.

Authors:  A Rötig; E L Appelkvist; V Geromel; D Chretien; N Kadhom; P Edery; M Lebideau; G Dallner; A Munnich; L Ernster; P Rustin
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

5.  Neonatal presentation of coenzyme Q10 deficiency.

Authors:  S Rahman; I Hargreaves; P Clayton; S Heales
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

6.  Coenzyme Q is an obligatory cofactor for uncoupling protein function.

Authors:  K S Echtay; E Winkler; M Klingenberg
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

7.  The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin.

Authors:  M C Moreira; C Barbot; N Tachi; N Kozuka; E Uchida; T Gibson; P Mendonça; M Costa; J Barros; T Yanagisawa; M Watanabe; Y Ikeda; M Aoki; T Nagata; P Coutinho; J Sequeiros; M Koenig
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

8.  Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene.

Authors:  H Date; O Onodera; H Tanaka; K Iwabuchi; K Uekawa; S Igarashi; R Koike; T Hiroi; T Yuasa; Y Awaya; T Sakai; T Takahashi; H Nagatomo; Y Sekijima; I Kawachi; Y Takiyama; M Nishizawa; N Fukuhara; K Saito; S Sugano; S Tsuji
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

Review 9.  Friedreich ataxia: a paradigm for mitochondrial diseases.

Authors:  Hélène Puccio; Michel Koenig
Journal:  Curr Opin Genet Dev       Date:  2002-06       Impact factor: 5.578

10.  Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency.

Authors:  S Di Giovanni; M Mirabella; A Spinazzola; P Crociani; G Silvestri; A Broccolini; P Tonali; S Di Mauro; S Servidei
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

View more
  133 in total

1.  Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.

Authors:  Eduardo Machuca; Geneviève Benoit; Fabien Nevo; Marie-Josèphe Tête; Olivier Gribouval; Audrey Pawtowski; Per Brandström; Chantal Loirat; Patrick Niaudet; Marie-Claire Gubler; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

Review 2.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

3.  A history of mitochondrial diseases.

Authors:  Salvatore Dimauro
Journal:  J Inherit Metab Dis       Date:  2010-05-21       Impact factor: 4.982

Review 4.  The clinical maze of mitochondrial neurology.

Authors:  Salvatore DiMauro; Eric A Schon; Valerio Carelli; Michio Hirano
Journal:  Nat Rev Neurol       Date:  2013-07-09       Impact factor: 42.937

5.  Mitochondrial disorders of the nuclear genome.

Authors:  C Angelini; L Bello; M Spinazzi; C Ferrati
Journal:  Acta Myol       Date:  2009-07

6.  Mutant COQ2 in multiple-system atrophy.

Authors:  Catarina M Quinzii; Michio Hirano; Salvatore DiMauro
Journal:  N Engl J Med       Date:  2014-07-03       Impact factor: 91.245

Review 7.  CoQ10 a super-vitamin: review on application and biosynthesis.

Authors:  Shraddha Shukla; Kashyap Kumar Dubey
Journal:  3 Biotech       Date:  2018-05-09       Impact factor: 2.406

Review 8.  Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.

Authors:  Maria Andrea Desbats; Giada Lunardi; Mara Doimo; Eva Trevisson; Leonardo Salviati
Journal:  J Inherit Metab Dis       Date:  2014-08-05       Impact factor: 4.982

Review 9.  Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.

Authors:  M M Löwik; P J Groenen; E N Levtchenko; L A Monnens; L P van den Heuvel
Journal:  Eur J Pediatr       Date:  2009-06-27       Impact factor: 3.183

10.  Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects.

Authors:  Luis C López; Catarina M Quinzii; Estela Area; Ali Naini; Shamima Rahman; Markus Schuelke; Leonardo Salviati; Salvatore Dimauro; Michio Hirano
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.